Health professionals reminded of Zostavax safety risk

The TGA has received a report of a death occurring in a person with pre-existing compromised immune function after receiving Zostavax The vaccine for the prevention of herpes zoster has been included on the National Immunisation Program since 1 November 2016 for patients 70 years of age. A five-year catch-up program for people aged 71-79 years is also underway.

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous World news wrapup: 9 March 2017
Next Lucy Walker Chemmart Goondiwindi is Pharmacy of the Year